Search results
Merck's vaccine approval poses threat to one of Pfizer's top-selling products
Morningstar· 3 days agoMerck & Co. Inc. on Monday gained U.S. regulatory approval for a vaccine that could become a tough competitor to one of Pfizer Inc.'s top-selling products ...
Kansas Attorney General Kris Kobach sues Pfizer over marketing of COVID-19 vaccine
The Kansas City Star· 4 days agoKansas Attorney General Kris Kobach is suing the pharmaceutical company Pfizer, alleging it deceptively marketed its COVID-19 vaccine. The lawsuit, filed ...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 15 hours agoMethylmalonic acidemia is a rare, genetic disease that prevents the body from breaking down proteins...
Analysts Set Pfizer Inc. (NYSE:PFE) Price Target at $35.86
ETF DAILY NEWS· 1 day agoPfizer Inc. (NYSE:PFE – Get Free Report) has been assigned an average rating of “Hold” from the fifteen ratings firms that are currently covering the stock, MarketBeat Ratings ...
Feds try to delay release of non-public COVID vaccine safety data until at least 2026
Just the News· 1 day agoThe Biden administration is seeking to delay until at least 2026 the release of COVID-19 vaccine...
Better High-Yield Dividend Stock: Pfizer vs. Bristol Myers Squibb
The Motley Fool via AOL· 3 days agoImage Source: Getty Images. Here is a head-to-head comparison of these popular healthcare dividend...
Merck wins U.S. approval for pneumonia vaccine to rival Pfizer’s
Crain's New York Business· 3 days agoCapvaxive has the potential to become the preferred vaccine given studies have shown it protects...
Merck wins FDA OK for vaccine rival to Pfizer’s pneumococcal shot
BioPharma Dive via Yahoo Finance· 3 days agoDive Insight: Merck currently sells two pneumococcal vaccines. One, dubbed Pneumovax 23, is for...
Pfizer stock price analysis: how PFE became a fallen angel | Invezz
Invezz· 3 days agoPfizer (NYSE: PFE) stock price has crashed hard in the past few years as demand for Covid-19 ...
MSD competes with Pfizer in pneumococcal vaccine market after FDA approval
Pharmaceutical Technology via Yahoo Finance· 3 days agoWalter Orenstein, a member of MSD’s scientific advisory committee said: “Capvaxive is designed to...